Monday, August 19, 2013

SMIP004 - the next drug for prostrate cancer?

Hi all,

I am pleased to read the announcement in July 2013 of Sanford- Burnham's research into SMIP004. I am all for the approach to down regulate the androgen receptors of cancerous cells. This is seen to be the first stage to arrest the rapid growing of the cancerous cells leading to metastasis.

SMIP004 is specifically good with prostrate cancer patients who have developed into the castration resistant stage and have cancer cells who are insensitive to androgen dripivation therapy.
Let us pray that SMIP004 will be successfully tried out in vivo and accepted by the FDA soonest.

Visit   Here
 for details.

Take care

Allen Lai

No comments:

Post a Comment